Related Experiment Video
Updated: Jan 8, 2026

Endotracheal Intubation via Tracheotomy and Subsequent Thoracotomy in Rats for Non-Survival Applications
Published on: March 15, 2024
Hyperkalemic emergency department patients intubated with rocuronium or succinylcholine: Retrospective study of
Patricia E Simmer1, Michael Perza2, Young D Cho1
1Emergency Medicine/Internal Medicine at Christiana Care Health System in Newark, Delaware 19718, USA.
Study Objective:
Emergency department (ED) clinicians often avoid succinylcholine due to concerns about potassium elevation leading to adverse events, though clinical evidence beyond case reports is limited. Rocuronium is a non-depolarizing paralytic that does not affect potassium levels. Therefore, it is perceived as safer despite causing longer paralysis than succinylcholine. This study aimed to compare adverse clinical outcomes in patients with pre-existing hyperkalemia who received either succinylcholine or rocuronium during rapid sequence intubation (RSI) in the ED.
Methods:
We conducted a retrospective cohort study of all ED patients aged ≥18 years presenting between October 2015 and July 2024 with initial serum potassium >5.5 mmol/L who underwent RSI with either rocuronium or succinylcholine. Data included demographics, medical history, lab values, medication administration, hospital course, and chart-reviewed details of adverse events. The primary outcome was death within 24 hours of RSI. The secondary outcome was cardiac arrest within 1 hour of RSI.
Results:
434 patients were included in analysis: 310 were paralyzed with rocuronium and 124 with succinylcholine. There was no significant difference in 24-hour mortality (rocuronium 10.0%, succinylcholine 10.5%, p=0.989). Cardiac arrest within 1 hour occurred in 7 cases (1.6% overall). 6 cases were in the rocuronium group (1.9%) and 1 in the succinylcholine group (0.8%, p=0.758). None of these arrests were fatal. Regression analysis showed no association between paralytic choice and 24-hour mortality (OR 0.911, 95% CI 0.414-2.00). Among succinylcholine cases, potassium level was not associated with increased 24-hour mortality (OR 1.311, 95% CI 0.359-4.780).
Conclusion:
We found no statistically significant difference in clinical adverse events between succinylcholine and rocuronium in hyperkalemic ED patients. While limited by its retrospective design, this study questions the presumed clinical importance of potassium levels in paralytic selection for RSI.
More Related Videos
05:39Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
07:52Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department
Published on: January 29, 2011
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Skeletal Muscle Relaxants: Therapeutic Uses
Endotracheal Intubation II: Nursing Management
1. Nursing Care of Patients Before Intubation
Before the endotracheal intubation procedure, nurses play an essential role in ensuring the process goes smoothly. The nurses must be familiar with intubation...
Endotracheal Tube Extubation
Procedure
Extubation removes the endotracheal tube (ETT) from the patient on mechanical ventilation. It requires a well-coordinated, multidisciplinary approach involving physicians, nurses, respiratory therapists, and other healthcare professionals....